DAX23.465 +1,0%Est505.574 +0,8%MSCI World4.343 -0,1%Top 10 Crypto12,19 -2,0%Nas23.026 +0,7%Bitcoin75.183 -0,4%Euro1,1584 +0,1%Öl62,75 +0,2%Gold4.158 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 DroneShield A2DMAA Bayer BAY001 Alphabet A (ex Google) A14Y6F RENK RENK73 Novo Nordisk A3EU6F Lufthansa 823212 Siemens Energy ENER6Y Amazon 906866 Deutsche Telekom 555750 Tesla A1CX3T HENSOLDT HAG000 TKMS thyssenkrupp Marine Systems TKMS00 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Dow schließt deutlich stärker -- DAX letztlich fester -- Voting über CureVac-BioNTech-Fusion -- Zoom, D-Wave, Kohl's, Apple, Rheinmetall & Co., DroneShield, Tesla, Alibaba, Gold, AMD, TKMS im Fokus
Top News
NVIDIA-Aktie als KI-Gigant: Microsofts AI-Chef warnt vor KI-Superintelligenz NVIDIA-Aktie als KI-Gigant: Microsofts AI-Chef warnt vor KI-Superintelligenz
Krypto-Korrektur als Chance: Warum Cathie Woods ARK Invest jetzt massiv nachlegt Krypto-Korrektur als Chance: Warum Cathie Woods ARK Invest jetzt massiv nachlegt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Insmed Aktie

Kaufen
Verkaufen
Insmed Aktien-Sparplan
180,00 EUR -3,00 EUR -1,64 %
BMN
209,02 USD +0,04 USD +0,02 %
nachbörslich
BTT
Insmed jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.38,15 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JJA3

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4576693075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolINSM

Insmed Aktien News

DatumMeistgelesen
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Chardan's 7th Annual Genetic Medicines Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
PR NewswireINSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
PR NewswireInsmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Reports First Quarter 2023 Financial Results and Provides Business Update
PR NewswireInsmed to Host Investor and Analyst Event on May 8, 2023
PR NewswireInsmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
PR NewswireInsmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at Two March Conferences
PR NewswireInsmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
PR NewswireInsmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
PR NewswireInsmed To Present at the SVB Securities Global Biopharma Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed To Present at the 41st Annual J.P. Morgan Healthcare Conference
PR NewswireInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireInsmed To Present at the Nasdaq 47th Investor Conference

Insmed News

Insmed News: auf dieser Seite finden Sie alle Insmed News und Nachrichten zur Insmed Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Insmed News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Insmed News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.